Long-Acting Peptide Formulation Advanced from Formulation Optimization to Phase I
Case Studies

Share

Long-Acting Peptide Formulation Advanced from Formulation Optimization to Phase I

Introduction

Learn about how a Phosphorex helped a client developing a long-acting peptide therapy for a rare autoimmune disease overcome significant formulation and scalability challenges that threatened progress toward clinical development. Theresa Logan, Head of Laboratory Operations at Phosphorex, shares her insights on the challenges her client faced.

“This program was essential to our client’s ability to stay competitive in the market. Successfully formulating, then scaling a process that accomplished their objectives was incredibly rewarding.”

Theresa Logan
Head of Laboratory Operations

Read Success Story